Cargando…

Measles Vaccine Virus RNA in Children More Than 100 Days after Vaccination

Measles vaccines have been in use since the 1960s with excellent safety and effectiveness profiles. Limited data are available on detection of measles vaccine virus (MeVV) RNA in human subjects following vaccination. Available evidence suggests MeVV RNA can be identified up to 14 days after vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	McMahon, Jamie, Mackay, Ian M, Lambert, Stephen B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669751/ https://www.ncbi.nlm.nih.gov/pubmed/31295941 http://dx.doi.org/10.3390/v11070636

Ejemplares similares

Laboratory methods supporting measles surveillance in Queensland, Australia, 2010–2017
por: McMahon, Jamie L., et al.
Publicado: (2020)

Measles at Work: Status of Measles Vaccination at a Multinational Company
por: Moussli, Nora, et al.
Publicado: (2019)

Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
por: Hansen, Jesper Sloth, et al.
Publicado: (2018)

A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults
por: Sasaki, Hiraku, et al.
Publicado: (2019)

Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017)

Are Measles More Dangerous in Grown-up Persons Than in Children?
por: Mynter, Herman
Publicado: (1880)

A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity
por: Julik, Emily, et al.
Publicado: (2017)

Measles Virus Hemagglutinin: Structural Insights into Cell Entry and Measles Vaccine
por: Hashiguchi, Takao, et al.
Publicado: (2011)

Prevalence of measles in vaccinated and non-vaccinated children
por: Zahoor, Muhammad Asif, et al.
Publicado: (2015)

Ethnicity and Delay in Measles Vaccination in a Nairobi Slum
por: Ettarh, Remare R., et al.
Publicado: (2012)

CEPI launches 100-day vaccine “moonshot”
por: Usher, Ann Danaiya
Publicado: (2022)

Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine
por: Park, Jung Wan, et al.
Publicado: (2019)

Attenuated measles virus as a vaccine vector
por: Zuniga, Armando, et al.
Publicado: (2007)

Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016)

Measles Vaccination Elicits a Polyfunctional Antibody Response, Which Decays More Rapidly in Early Vaccinated Children
por: Brinkman, Iris D, et al.
Publicado: (2021)

Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009)

93. Novel recombinant measles virus vaccine prevents measles virus disease in rhesus macaques
por: Rubens, Jessica, et al.
Publicado: (2022)

Mass Measles Vaccination
por: Ghorbani, Gholam Ali
Publicado: (2012)

Can early measles vaccination control both measles and respiratory syncytial virus infections?
por: Do, Lien Anh Ha, et al.
Publicado: (2022)

Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2020)

A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model
por: Strohmeier, Shirin, et al.
Publicado: (2021)

A Fatal Case of Disseminated Tuberculosis Coincident with Measles-Rubella Vaccination
por: Cheong, Hae-Kwan, et al.
Publicado: (2010)

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
por: Botton, Jérémie, et al.
Publicado: (2022)

Time of day of vaccination does not relate to antibody response to thymus-independent vaccinations
por: Whittaker, Anna C., et al.
Publicado: (2022)

Self‐Assembly of Measles Virus Nucleocapsid‐like Particles: Kinetics and RNA Sequence Dependence
por: Milles, Sigrid, et al.
Publicado: (2016)

Measles on the Rise: The importance of vaccination
por: Said, Elias A., et al.
Publicado: (2019)

Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US)
por: Carias, Cristina, et al.
Publicado: (2021)

Suicide gene-armed measles vaccine virus for the treatment of AML
por: Maurer, Stefanie, et al.
Publicado: (2019)

100. Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant
por: Mitre, Xhoi, et al.
Publicado: (2021)

Molecular Epidemiology of Measles Virus before and after the 2003 Mass Vaccination Campaign for Measles/Rubella in Iran
por: Naseri, M, et al.
Publicado: (2011)

Characteristics and Genomic Diversity of Measles Virus From Measles Cases With Known Vaccination Status in Shanghai, China
por: Cui, Xiaoxian, et al.
Publicado: (2022)

Measles Vaccination Coverage and Cases among Vaccinated Persons
por: Althaus, Christian L., et al.
Publicado: (2015)

Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2019)

Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
por: Randi, Bruno Azevedo, et al.
Publicado: (2023)

Timeliness Vaccination of Measles Containing Vaccine and Barriers to Vaccination among Migrant Children in East China
por: Hu, Yu, et al.
Publicado: (2013)

Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival
por: Benn, Christine S., et al.
Publicado: (2020)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC
por: Farcet, Jean-Baptiste, et al.
Publicado: (2023)

Evidence of recombination among early-vaccination era measles virus strains
por: Schierup, Mikkel H, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3un8emg5qfhjb6eofhj97bqugh